---
layout: post
title: "Advisory Committee; Bone, Reproductive and Urologic Drugs Advisory Committee; Change of Name and Function; Technical Amendment"
date: 2026-02-05 18:58:33 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-05965
original_published: 2022-03-23 00:00:00 +0000
significance: 8.00
---

# Advisory Committee; Bone, Reproductive and Urologic Drugs Advisory Committee; Change of Name and Function; Technical Amendment

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** March 23, 2022 00:00 UTC
**Document Number:** 2022-05965

## Summary

The Food and Drug Administration (FDA or Agency) is amending the standing advisory committees' regulations to change the name and function of the Bone, Reproductive and Urologic Drugs Advisory Committee. This action is being taken to reflect changes made to the charter for this advisory committee.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/03/23/2022-05965/advisory-committee-bone-reproductive-and-urologic-drugs-advisory-committee-change-of-name-and)
- API: https://www.federalregister.gov/api/v1/documents/2022-05965

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
